| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 0 | 0 | 0 | 0 | 3.544 | 34.710 | 45.367 | 44.191 | 46.720 |
| Total Income - EUR | 0 | 0 | 0 | 0 | 0 | 5.995 | 35.030 | 45.376 | 46.415 | 46.319 |
| Total Expenses - EUR | 0 | 0 | 0 | 284 | 148 | 10.998 | 32.124 | 44.495 | 42.552 | 49.480 |
| Gross Profit/Loss - EUR | 0 | 0 | 0 | -284 | -148 | -5.003 | 2.906 | 881 | 3.863 | -3.161 |
| Net Profit/Loss - EUR | 0 | 0 | 0 | -284 | -148 | -5.109 | 2.241 | -60 | 3.421 | -3.628 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Medicago Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 352 | 177 | 40 | 0 | 0 |
| Current Assets | 45 | 45 | 44 | 43 | 42 | 4.435 | 9.854 | 11.029 | 14.468 | 11.363 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 3.513 | 7.840 | 7.959 | 11.004 | 9.519 |
| Receivables | 0 | 0 | 0 | 0 | 0 | 443 | 270 | 858 | 492 | 536 |
| Cash | 45 | 45 | 44 | 43 | 42 | 478 | 1.744 | 2.212 | 2.973 | 1.308 |
| Shareholders Funds | 45 | 45 | 44 | -241 | -384 | -5.486 | -3.123 | -3.193 | 237 | -3.392 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 0 | 0 | 0 | 284 | 426 | 10.272 | 13.155 | 14.262 | 14.231 | 14.755 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4773 - 4773" | |||||||||
| CAEN Financial Year |
4771
|
|||||||||
Comments - Medicago Srl